Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Influenza vaccination.

M A Riddiough, J E Sisk, J C Bell

    JAMA
    |June 17, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Influenza vaccination for older adults saved money and improved health. For younger high-risk adults, vaccination offered health gains at a low cost, highlighting its value as preventive care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Robust envelope exchange platform for oncolytic measles virus.

    Journal of virological methods·2022
    Same author

    Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination.

    Nature communications·2021
    Same author

    The Canadian Cancer Research Conference 2019.

    Current oncology (Toronto, Ont.)·2020
    Same author

    ACACIA MANGIUM: A TROPICAL FOREST TREE OF THE COASTAL LOWLANDS WITH LOW GENETIC DIVERSITY.

    Evolution; international journal of organic evolution·2017
    Same author

    Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer.

    Cancer gene therapy·2016
    Same author

    School performance for children with cleft lip and palate: a population-based study.

    Child: care, health and development·2016
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Public Health
    • Health Economics
    • Preventive Medicine

    Background:

    • Influenza poses a significant health burden, particularly for elderly and high-risk populations.
    • Evaluating the economic impact of preventive health measures like vaccination is crucial for healthcare policy.

    Purpose of the Study:

    • To conduct a cost-effectiveness analysis of influenza vaccination for different age groups.
    • To assess the economic and health benefits of influenza vaccination for the Medicare program.

    Main Methods:

    • Cost-effectiveness analysis was employed to evaluate influenza vaccination strategies.
    • Data from the 1971-1972 through 1977-1978 influenza seasons were analyzed.

    Main Results:

    • Vaccinating individuals aged 65 and older resulted in net medical cost savings and improved health outcomes.
    Keywords:
    Health Care and Public Health

    Related Experiment Videos

  • Vaccinating high-risk adults aged 15-64 years yielded health improvements at a low cost per year of healthy life gained.
  • Medicare coverage for influenza vaccination during the study period represented a cost-effective investment, with varying costs per year of healthy life gained depending on included factors.

    • Conclusions:

    • Influenza vaccination is a cost-effective preventive technology for both elderly and high-risk adult populations.
    • Further epidemiologic research is needed to understand influenza's spread and impact.
    • Public policy should promote influenza vaccination among high-risk groups to maximize health and economic benefits.